New Faces Will Lead Office Of Regulatory Affairs As Two Top Officials Depart
Executive Summary
The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing inspections and enforcement activity
You may also be interested in...
FDA China Office Will Be Test Of International Diplomacy, Intra-Agency Politics
FDA's opening of a China Office will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments, but in restructuring itself to operate on a world-wide footing
FDA China Office Will Be Test Of International Diplomacy, Intra-Agency Politics
FDA's opening of a China Office will be an early test of how the agency handles the challenges of globalization, not only in working with foreign governments, but in restructuring itself to operate on a world-wide footing
CDER, ORA To Be Major Beneficiaries Of Speedier FDA Hiring Process
As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels